These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5783221)

  • 1. [Study on the adverse effects of secondary antituberculous drugs, with special reference to mental disorders induced by cycloserine and ethionamide].
    Ono K; Hashigami Y; Itonaga K; Aida Y; Fujino S
    Iryo; 1969 Jan; 23(1):85-91. PubMed ID: 5783221
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
    Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
    Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible pellagra-like encephalopathy with ethionamide and cycloserine.
    Swash M; Roberts AH; Murnaghan DJ
    Tubercle; 1972 Jun; 53(2):132-6. PubMed ID: 4261138
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of treatment of pulmonary tuberculosis with cycloserine in association with other drugs.
    Bethlem N
    Scand J Respir Dis Suppl; 1970; 71():244-9. PubMed ID: 5271994
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance to cycloserine.
    Riska N
    Scand J Respir Dis Suppl; 1970; 71():209-16. PubMed ID: 5271988
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secondary antitubercular drugs in the treatment of childhood tuberculosis].
    de Lacerda A
    Rev Port Pediatr Pueric; 1967 May; 30(5):149-56. PubMed ID: 4303078
    [No Abstract]   [Full Text] [Related]  

  • 8. [Triple placebo test for comparison of side effects of terizidone (terivalidin) and cycloserine].
    Böszörményi M
    Int J Clin Pharmacol; 1973 Aug; 8(1):37-41. PubMed ID: 4580381
    [No Abstract]   [Full Text] [Related]  

  • 9. [Collateral toxic effects of antitubercular drugs: acute psychopathies caused by cycloserine. (Case reports)].
    Zanotelli F; Ghidini O; Bertoni L
    G Clin Med; 1967 Sep; 48(9):972-84. PubMed ID: 5609866
    [No Abstract]   [Full Text] [Related]  

  • 10. Suicide of two patients during the postoperative course after pulmonary resection: possible effect of cycloserine.
    Esteves Pinto E
    Scand J Respir Dis Suppl; 1970; 71():256-8. PubMed ID: 5271997
    [No Abstract]   [Full Text] [Related]  

  • 11. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with cycloserine.
    Dissmann E
    Scand J Respir Dis Suppl; 1970; 71():239-43. PubMed ID: 5317744
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Buenos Aires, Argentina.
    Palmero DJ; Ambroggi M; Brea A; De Lucas M; Fulgenzi A; Martínez D; Mosca C; Musella R; Natiello M; Gonzalez C; Abbate E
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):778-84. PubMed ID: 15182150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropsychiatric incidences in antitubercular treatment consisting of isoniazid or isoniazid and ethionamide (8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 127(2):201-26. PubMed ID: 4254305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 2(2):201-26. PubMed ID: 5385334
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psychoses caused by cycloserine].
    Gori EC; Teti V
    G Ital Mal Torace; 1968; 22(6):359-68. PubMed ID: 5729888
    [No Abstract]   [Full Text] [Related]  

  • 19. [Manifestations of a rheumatic type caused by antituberculosis chemotherapy].
    Anastasatu C; Kauffmann S; Iancovici O
    Med Interna (Bucur); 1969 May; 21(5):557-60. PubMed ID: 5307329
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of the adverse effects of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Rózewska M
    Gruzlica; 1969 Dec; 37(12):1103-6. PubMed ID: 5368636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.